Screen to Save 2: Rural Cancer Screening Educational Intervention
Cancer · Colorectal Cancer
Bottom Line
View on ClinicalTrials.gov: NCT04414306 ↗Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Online educational video and website module (Other)
- Age
- Adult, Older Adult · 45+ yrs
- Sex
- All
- Sponsor
- Dartmouth-Hitchcock Medical Center
- Primary completion
- Nov 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Correct Responses Regarding Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening |
-.5; 0; 1; 2; 13; 1 | <.0001 sig |
| PRIMARY Change in Colorectal Cancer Screening and Other Risk Behavior Intentions |
4.54; 4.66; 4.39; 4.5; 4.08; 4.22 | .001 sig |
Summary
Eligibility Criteria
Inclusion Criteria
- Resident of one of the RUCC 7-9 counties in New Hampshire or Vermont (Coos or Sullivan County, NH; Caledonia, Windsor, Windham, Orange, Orleans, Lamoille, or Essex County, VT) and
- Age 45-74 at the time of enrollment in the study
Exclusion Criteria
- Cognitive impairment preventing participation in informed consent process
Three-Month Follow-Up Survey Inclusion Criteria:
A participant will be eligible for inclusion in the three-month follow-up survey if the participant completed the pre-test, educational intervention, and post-test and at the time of initial participation:
- Answered a colorectal cancer screening history question indicating that the participant has never received colorectal cancer screening OR does not know if he/she has received colorectal cancer screening previously OR
- Answered a series of questions indicating that the participant received prior colorectal cancer screening but may be overdue for colorectal cancer screening based on the type of colorectal cancer screening last reported and screening guidelines for the frequency of re-screening.
Six-Month Follow-Up Survey Inclusion Criteria:
A participant will be eligible for inclusion in the six-month follow-up survey if the participant participated in the three-month-follow up survey and at that time reported that having:
- A FIT/FOBT screening or Cologuard (stool) screening performed since the time of initial study participation, but having not received the results
- An abnormal FIT/FOBT, or Cologuard (stool) screening since the time of initial study participation, but had not received a diagnostic colonoscopy
- A colonoscopy since the time of initial study participation, but had not received the final results
Data sourced from ClinicalTrials.gov (NCT04414306). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.